“Adenocarcinoma”的搜索结果，显示 91-100 项，共有 9184 项

1. 血液科- 临床试验- 妙佑医疗国际

   ... adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC).

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   DISEASE STATE - Potentially operable or borderline resectable pancreatic adenocarcinoma as assessed by standard CT criteria and histologically confirmed. - ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients with Barrett's Esophagus (BE) or Esophageal Adenocarcinoma (EAC) that are planned for Endoscopic Submucosal Dissection (ESD) treatment. Exclusion ...

5. 神经科- 临床试验- 妙佑医疗国际

   ... adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC).

7. 神经科- 临床试验- 妙佑医疗国际

   ... adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   DNA Methylation in Adenocarcinoma of the Prostate: Tissue Validation of Biomarkers and Pilot Testing in Blood. Rochester, Minn. The study will be performed ...

9. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   DISEASE STATE - Potentially operable or borderline resectable pancreatic adenocarcinoma as assessed by standard CT criteria and histologically confirmed. - ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... adenocarcinoma, (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 ...